Antigenic changes of a murine lymphoma by in vivo treatment with triazene derivatives

Tumour inhibitory triazenes: Structural requirements for an active metabolite

1976 • 122 citations

Antigenic changes of L1210 leukemia in mice treated with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide.

1972 • 71 citations

Mechanism of action and pharmacology studies with DTIC (NSC-45388).

1976 • 56 citations

Drug-Mediated Antigenic Changes in Murine Leukemia Cells: Antagonistic Effects of Quinacrine, an Antimutagenic Compound23

1980 • 51 citations

Depressed T-cell reactivity and suppressor activity of lymphoid cells from cyclophosphamide-treated mice

1976 • 36 citations

Differential tumor immunogenicity of L1210 and its sublines. I. Effect of an increased antigen density on tumor cell surfaces on primary B cell responses in vitro.

1977 • 28 citations

THE IMMUNODEPRESSIVE AND HEMATOTOXIC ACTIVITY OF IMIDAZOLE-4-CARBOXAMIDE,5-(3,3-DIMETHYL-1-TRIAZENO) IN MICE

1976 • 25 citations

Immunopharmacology of 5-(3,3-dIMETHYL-1-triazeno)-imidazole-4-carboxamide (DTIC) (DTIC)

1975 • 17 citations

Influence of Serum Albumins on Decomposition Rates of Para- Substituted 1-phenyl-3-methyltriazenes and 5-(3-methyl-1-triazeno)imidazole-4-carboxamide in Near Physiological Conditions

1981 • 12 citations